BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6027560)

  • 1. Investigation of correlations occurring between the urinary excretion of calcium, nitrogen, phosphorus and hydroxyproline after calcium administration in articular disease.
    Stĕpán J; Brémová A
    Acta Rheumatol Scand; 1967; 13(2):150-60. PubMed ID: 6027560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium, phosphorus, hydroxyproline and nitrogen in inflammatory joint diseases].
    Stĕpán J
    Z Rheumatol; 1977; 36(1-2):60-72. PubMed ID: 842146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An anabolic agent of the androstane-pyrazole type and the evaluation of anabolic treatment].
    Stĕpán J
    Verh Dtsch Ges Rheumatol; 1969; 1():401-5. PubMed ID: 5403654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary hydroxyproline excretion in generalized bone diseases].
    Czitober H; Raab W
    Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stromba in disorders of the locomotion apparatus].
    Stĕpán J; Brémová A
    Med Klin; 1967 Sep; 62(38):1470-4. PubMed ID: 5595348
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary total hydroxyproline, calcium and phosphorus excretion after administration of calcium and oestrogen to postmenopausal women.
    Dequeker J; Heylen H; Van Steenkiste J; Vroninkx R
    Pharmacology; 1972; 7(5):321-6. PubMed ID: 4644003
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary excretion of prolylhydroxyproline in rheumatic diseases.
    Bienenstock HKIBRICK AC
    Ann Rheum Dis; 1969 Jan; 28(1):28-30. PubMed ID: 5305862
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic response of collagen to trauma: the relationship of urinary nitrogen and hydroxyproline.
    Klein L
    J Trauma; 1967 May; 7(3):343-56. PubMed ID: 6024136
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiological osteoporosis: correlation with dietary and biochemical findings.
    Reshef A; Schwartz A; Ben-Menachem Y; Menczel J; Guggenheim K
    J Am Geriatr Soc; 1971 May; 19(5):391-402. PubMed ID: 5093758
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for urinary hydroxyproline determination].
    Burkhardt H; Wepler R; Rommel K
    Dtsch Med Wochenschr; 1976 Sep; 101(38):1394-7. PubMed ID: 782814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hydroxyproline excretion in urine in chronic connective tissue disease].
    Emmrich R
    Z Gesamte Inn Med; 1970 Dec; 25(23):1062-5. PubMed ID: 4397769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary excretion of hydroxyproline, calcium, phosphorus and magnesium in chronic hepatitis].
    Hesch R; Braun JS; Banzer D
    Acta Hepatogastroenterol (Stuttg); 1972; 19(4):224-33. PubMed ID: 4663712
    [No Abstract]   [Full Text] [Related]  

  • 13. An epidemiological study of osteoporosis in Israel.
    Guggenheim K; Menczel J; Reshef A; Schwartz A; Ben-Menachem Y; Bernstein DS; Hegsted M; Stare FJ
    Arch Environ Health; 1971 Feb; 22(2):259-64. PubMed ID: 5540112
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological exploration of osteoporosis (author's transl)].
    Hioco D
    J Belge Rhumatol Med Phys; 1973 Sep; 28(5):287-92. PubMed ID: 4794041
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal acid, urinary cyclic AMP, and hydroxyproline excretion as affected by level of protein, sulfur amino acid, and phosphorus intake.
    Schuette SA; Hegsted M; Zemel MB; Linkswiler HM
    J Nutr; 1981 Dec; 111(12):2106-16. PubMed ID: 6273514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of porcine calcitonin in osteoporosis.
    Melick RA; Martin TJ; Storey E
    Aust N Z J Med; 1973 Jun; 3(3):285-9. PubMed ID: 4517226
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest.
    Hulley SB; Vogel JM; Donaldson CL; Bayers JH; Friedman RJ; Rosen SN
    J Clin Invest; 1971 Dec; 50(12):2506-18. PubMed ID: 5129304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the urinary hydroxyproline level in the screening for collagen diseases].
    Gambella GR; Zunino M
    Minerva Med; 1986 Apr; 77(16):607-12. PubMed ID: 3703359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyaluronic acid and N-terminal procollagen-III-peptide in the urine in inflammatory and degenerative joint diseases].
    Respondek M; Seibel MJ; Lautenschläger J; Müller W
    Z Rheumatol; 1989; 48(3):117-22. PubMed ID: 2789456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycan excretion in rheumatic diseases.
    Kéry V; Orlovská M; Stancíková M; Risko M; Zlnay D
    Clin Chem; 1992 Jun; 38(6):841-6. PubMed ID: 1597009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.